Sector Update: Healthcare

By Staff,

Shutterstock photo

Healthcare shares are flat in pre-market trade.

Oramed Pharmaceuticals ( ORMP ) was down about 16% in pre-market trade after the developer of oral drug delivery systems said it entered into definitive agreements with investors to purchase an aggregate of 1,580,000 shares of common stock at a price of $10.00 per share in a registered direct offering.

And bluebird bio, Inc. ( BLUE ) a clinical-stage company that develops potentially transformative gene therapies for severe genetic and orphan diseases, was recently added to the NASDAQ Biotechnology Index effective prior to the market open on December 23, 2013.

Finally, DS Healthcare ( DSKX ) said Thursday that it has entered and consummated a securities purchase agreement with an accredited investor for the sale of 1.512 million shares of the company's common stock, with gross proceeds of $2.42 million.

The shares were offered and sold solely to accredited investors on a private placement basis. Shares closed at $2.30 with a 52-week range of $1.41 - $3.94.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: BLUE , DSKX , ORMP

More from MT Newswires


MT Newswires

MT Newswires

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by